Financials data is unavailable for this security.
View more
Year on year Immunocore Holdings PLC had net income fall 5.22% from a loss of 52.54m to a larger loss of 55.29m despite a 43.05% increase in revenues from 174.36m to 249.43m.
Gross margin | 99.41% |
---|---|
Net profit margin | -18.99% |
Operating margin | -21.78% |
Return on assets | -6.75% |
---|---|
Return on equity | -15.02% |
Return on investment | -8.35% |
More ▼
Cash flow in USDView more
In 2023, Immunocore Holdings PLC increased its cash reserves by 9.98%, or 40.15m. Cash Flow from Financing totalled 34.35m or 13.77% of revenues. In addition the company generated 2.94m in cash from operations while cash used for investing totalled 5.43m.
Cash flow per share | -0.9965 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 7.18 |
---|---|
Tangible book value per share | 7.18 |
More ▼
Balance sheet in USDView more
Current ratio | 5.17 |
---|---|
Quick ratio | 5.15 |
Total debt/total equity | 1.22 |
---|---|
Total debt/total capital | 0.5495 |
More ▼